The enzyme encoded by the ALOX15B gene has been linked to the development of atherosclerotic plaques in humans and in a mouse model of hypercholesterolemia. In vitro, these enzymes, which share 78% sequence identity, generate distinct products from their substrate arachidonic acid: the human enzyme, a 15-S-hydroperoxy product; and the murine enzyme, an 8-S-product. We probed the activities of these enzymes with nanodiscs as membrane mimics to determine whether they can access substrate esterified in a bilayer and characterized their activities at the membrane interface. We observed that both enzymes transform phospholipid-esterified arachidonic acid to a 15-S-product. Moreover, when expressed in transfected HEK cells, both enzymes result in significant increases in the amounts of 15-hydroxyderivatives of eicosanoids detected. In addition, we show that 15-LOX-2 is distributed at the plasma membrane when the HEK293 cells are stimulated by the addition Ca 2؉ ionophore and that cellular localization is dependent upon the presence of a putative membrane insertion loop. We also report that sequence differences between the human and mouse enzymes in this loop appear to confer distinct mechanisms of enzyme-membrane interaction for the homologues.A macrophage 2 activity has been linked to elevated levels of oxidized lipids through several experimental approaches that include the heterologous expression of human 15-LOX in a mouse model of hyperlipidemia (1) and pharmacological inhibition of 15-LOX activity (2, 3). These lipid oxidation products can enter the extracellular pool of cholesterol esters transported by LDL (4) and promote the pathological consequences of elevated LDL cholesterol levels (5). Macrophages that take up LDL laden with oxidized lipids are transformed to foam cells, an event that leads to further inflammation and apoptosis and results in the formation of atherosclerotic plaques. Recently, Magnusson et al. (6) demonstrated that silencing production of 15-LOX-2 (the product of the ALOX15B gene) in human macrophages decreased cellular lipid accumulation, the precipitating factor in foam cell formation. These results suggest that inhibition of 15-LOX-2 is a strategy for mitigating the development of cardiovascular disease.Lipoxygenases oxygenate arachidonic acid (AA) to form a stereo-and regiospecific isomer of hydroperoxyeicosatetraenoic acid (HpETE), and isoforms are named according to which carbon atom is oxygenated (for review see Refs. 7 and 8).In general, within a species, lipoxygenases that differ in regiospecificity share ϳ40% sequence identity. In contrast, betweenspecies LOX homologues are expected to share ϳ75% or better sequence identity and generate the same HpETE isomer. The mouse homologue of human 15-LOX-2, however, is an 8-LOX (m8S-LOX) with free AA as the substrate, and this altered regiospecificity appears to be unique to the mouse enzyme (9). We asked whether at the membrane and in a cellular context the mouse enzyme might also generate a 15-HpETE product. This information might prov...